Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs.

Use of biologics in rheumatoid arthritis: current and emerging paradigms of care. Clin Ther (2011) 1.29

Rheumatoid Arthritis: Early diagnosis and treatment outcomes. Caspian J Intern Med (2011) 0.94

Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis. Nanomedicine (Lond) (2010) 0.94

Chronic disease: when in doubt, consider accrual into a randomized controlled trial (RCT). Br J Clin Pharmacol (2008) 0.85

74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis. Arthritis Res Ther (2010) 0.83

Comparison of the second and third generation anti-cyclic citrullinated peptide antibody assays in the diagnosis of Japanese patients with rheumatoid arthritis. Rheumatol Int (2010) 0.83

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum (2006) 9.37

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum (2005) 8.47

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet (1997) 6.71

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum (2004) 6.22

COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum (2002) 5.57

Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med (2007) 5.05

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet (1999) 4.98

Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum (2002) 4.77

Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) (2004) 4.56

Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med (2001) 4.31

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. Arthritis Rheum (2005) 4.28

Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes. Arthritis Rheum (2002) 4.15

Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum (2007) 3.66

Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis (2002) 3.53

Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha agents in rheumatoid arthritis. Arthritis Rheum (2003) 3.18

Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum (2004) 3.00

Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2005) 2.92

Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study. Arthritis Rheum (2004) 2.36

The Norfolk Arthritis Register (NOAR). Clin Exp Rheumatol (2004) 1.60

Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study. Arthritis Rheum (2006) 1.40

Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression. Br J Rheumatol (1998) 1.33

Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis. Ann Rheum Dis (2004) 1.29

Appropriate and effective management of rheumatoid arthritis. Ann Rheum Dis (2004) 1.06

Early rheumatoid arthritis: strategies for prevention and management. Best Pract Res Clin Rheumatol (2007) 1.04

Databases of patients with early rheumatoid arthritis in the USA. Clin Exp Rheumatol (2004) 1.00

Drugs that block tumour necrosis factor: experience in patients with rheumatoid arthritis. Pharmacoeconomics (2004) 0.96

Rheumatoid arthritis: more aggressive approach improves outlook. Cleve Clin J Med (2004) 0.92

Biologics in rheumatoid arthritis. J Assoc Physicians India (2004) 0.85

Advances in the treatment of rheumatoid arthritis: old versus new therapies. Expert Opin Pharmacother (2002) 0.83

[Drug therapy of rheumatoid arthritis]. Orthopade (2003) 0.81

Early rheumatoid arthritis. Curr Opin Rheumatol (2007) 0.79

Pharmacological management of early rheumatoid arthritis--does combination therapy improve outcomes? J Rheumatol Suppl (2002) 0.79

Innovative treatment approaches for rheumatoid arthritis. Combination therapy. Baillieres Clin Rheumatol (1995) 0.78

Adalimumab therapy: clinical findings and implications for integration into clinical guidelines for rheumatoid arthritis. Drugs Today (Barc) (2005) 0.78

Recent advances in the treatment of rheumatoid arthritis. Clin Cornerstone (1999) 0.77

[The role of the conventional drugs in the treatment of rheumatoid arthritis]. Recenti Prog Med (2003) 0.77